CR — Crane Company
NYSE
Q1 2026 Earnings Call Summary
April 28, 2026
Crane Company Q1 2026 Earnings Call Summary
1. Key Financial Results and Metrics
- Adjusted EPS: $1.65, up 15% year-over-year.
- Total Sales: Increased by 25% compared to Q1 2025, with 4% core sales growth.
- Sales from Acquisitions: Contributed 18% to total sales, exceeding expectations.
- Adjusted Operating Profit: Increased by 29%, driven by higher core sales and productivity.
- Core FX-Neutral Backlog: Up 9% year-over-year, with a 3% sequential increase.
- Core Orders: Down 5% year-over-year, primarily due to a decline in Aerospace and Advanced Technologies.
2. Strategic Updates and Business Highlights
- CEO Transition: Alejandro A. Alcala emphasized a commitment to disciplined execution and agility in a rapidly evolving market.
- Acquisition Performance: Recent acquisitions (Druck, Panametrics, Reuter-Stokes, OPTECH) exceeded integration expectations, contributing significantly to performance.
- Aerospace and Advanced Technologies: Strong demand in defense and aerospace markets, with a backlog of nearly $1.2 billion.
- Process Flow Technologies: Solid performance with a focus on pharmaceuticals, wastewater, and cryogenics, despite a slight decline in core sales.
3. Forward Guidance and Outlook
- Adjusted Full-Year EPS Guidance: Raised to a range of $6.65 to $6.85, reflecting confidence despite macroeconomic uncertainties.
- Core Sales Growth Expectations: Aerospace and Advanced Technologies expected to grow at the high end of the 7% to 9% range. Process Flow Technologies forecasted to remain flat to low single digits.
- Margin Expectations: Anticipated improvements in margins, with a projected increase of approximately 50 basis points for the full year.
4. Bad News, Challenges, or Points of Concern
- Geopolitical Risks: Ongoing geopolitical tensions and elevated energy prices may impact commercial aftermarket demand.
- Commercial Aftermarket Decline: Expected decline in commercial aftermarket revenue, with guidance reflecting potential downturns.
- Chemical Sector Weakness: Continued sluggishness in the chemicals segment, with no clear inflection point in sight.
- Inflationary Pressures: Anticipated inflation in commodities and freight costs could pressure margins in the latter half of the year.
5. Notable Q&A Insights
- Acquisition Accretion: EPS accretion from acquisitions expected to be at least 15 cents for the full year, double previous estimates.
- M&A Pipeline: Strong activity in M&A with a healthy pipeline of opportunities, including both smaller bolt-on deals and larger acquisitions.
- Commercial Aftermarket Dynamics: While orders were up 11%, revenue declined 13% due to unfavorable comparisons; management remains cautiously optimistic about offsetting declines with military aftermarket growth.
- Capacity in Defense: Adequate capacity in defense businesses to meet potential increases in demand for missile-related products.
Overall, Crane Company reported a strong start to 2026, with solid financial results and strategic execution, while remaining vigilant about external challenges and market dynamics.
